This article was originally published in The Gray Sheet
E-commerce concern Chemdex inks definitive agreement to acquire healthcare purchasing e-commerce business Promedix.com for stock valued at $340 mil. Announced Sept. 22, the deal combines Promedix.com's "extensive healthcare industry experience and strong customer and supplier relationships with Chemdex's scalable technology platform and proven track record at providing end-to-end e-commerce solutions for industry-specific marketplaces," Chemdex states
You may also be interested in...
A 2008 law that limited exclusivity for certain antibiotics to three years does not apply to Allergan’s Avycaz, which combines an approved old antibiotic active moiety and a new active moiety, CDER exclusivity board concludes.
AstraZeneca and Novavax have not filed EUAs for their vaccines, and they never might. The pathway remains viable in the short-term, but as BLAs are approved and supplies are no longer short, the window may close.
Emergency use authorization in 12-15 year-olds follows announcement of a June advisory committee meeting on pediatric data requirements, including the FDA’s criteria for younger children. Authorization for US adolescents has raised ethical questions about prioritizing this lower-risk group over hard-hit populations overseas.